SASR Ex-Dividend Reminder - 2/10/14

Looking at the universe of stocks we cover at Dividend Channel, on 2/10/14, Sandy Spring Bancorp Inc (SASR) will trade ex-dividend, for its quarterly dividend of $0.18, payable on 2/19/14. As a percentage of SASR's recent stock price of $23.27, this dividend works out to approximately 0.77%, so look for shares of Sandy Spring Bancorp Inc to trade 0.77% lower — all else being equal — when SASR shares open for trading on 2/10/14.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for SASR, showing historical dividends prior to the most recent $0.18 declared by Sandy Spring Bancorp Inc:

SASR+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from SASR is likely to continue, and whether the current estimated yield of 3.09% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of SASR shares, versus its 200 day moving average:

Sandy Spring Bancorp Inc 200 Day Moving Average Chart

Looking at the chart above, SASR's low point in its 52 week range is $18.66 per share, with $29.45 as the 52 week high point — that compares with a last trade of $23.37.

In Thursday trading, Sandy Spring Bancorp Inc shares are currently up about 0.5% on the day.

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says